Global Prostate Cancer Diagnostics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

Global Prostate Cancer Diagnostics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

Table of Contents
1 Study Coverage
1.1 Prostate Cancer Diagnostics Product Introduction
1.2 Market by Type
1.2.1 Global Prostate Cancer Diagnostics Market Size Growth Rate by Type
1.2.2 Tumor Biomarker Tests
1.2.3 Imaging
1.2.4 Biopsy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Prostate Cancer Diagnostics Market Size Growth Rate by Application
1.3.2 age < 55
1.3.3 age 55-75
1.3.4 age > 75
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Prostate Cancer Diagnostics Market Size Estimates and Forecasts
2.1.1 Global Prostate Cancer Diagnostics Revenue 2015-2026
2.1.2 Global Prostate Cancer Diagnostics Sales 2015-2026
2.2 Prostate Cancer Diagnostics Market Size by Region: 2020 Versus 2026
2.3 Prostate Cancer Diagnostics Sales by Region (2015-2026)
2.3.1 Global Prostate Cancer Diagnostics Sales by Region: 2015-2020
2.3.2 Global Prostate Cancer Diagnostics Sales Forecast by Region (2021-2026)
2.3.3 Global Prostate Cancer Diagnostics Sales Market Share by Region (2015-2026)
2.4 Prostate Cancer Diagnostics Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Prostate Cancer Diagnostics Revenue by Region: 2015-2020
2.4.2 Global Prostate Cancer Diagnostics Revenue Forecast by Region (2021-2026)
2.4.3 Global Prostate Cancer Diagnostics Revenue Market Share by Region (2015-2026)
3 Global Prostate Cancer Diagnostics by Manufacturers
3.1 Global Top Prostate Cancer Diagnostics Manufacturers by Sales
3.1.1 Global Prostate Cancer Diagnostics Sales by Manufacturer (2015-2020)
3.1.2 Global Prostate Cancer Diagnostics Sales Market Share by Manufacturer (2015-2019)
3.2 Global Top Prostate Cancer Diagnostics Manufacturers by Revenue
3.2.1 Global Prostate Cancer Diagnostics Revenue by Manufacturer (2015-2020)
3.2.2 Global Prostate Cancer Diagnostics Revenue Share by Manufacturer (2015-2020)
3.3 Global Prostate Cancer Diagnostics Price by Manufacturer (2015-2020)
3.4 Competitive Landscape
3.4.1 Key Prostate Cancer Diagnostics Manufacturers Covered: Ranking by Revenue
3.4.2 Global Prostate Cancer Diagnostics Market Concentration Ratio (CR5 and HHI) & (2015-2020)
3.4.3 Global Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Prostate Cancer Diagnostics Manufacturing Base Distribution, Product Type
3.5.1 Prostate Cancer Diagnostics Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Prostate Cancer Diagnostics Product Type
3.5.3 Date of International Manufacturers Enter into Prostate Cancer Diagnostics Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Genomic Health
4.1.1 Genomic Health Corporation Information
4.1.2 Genomic Health Description, Business Overview
4.1.3 Genomic Health Prostate Cancer Diagnostics Products Offered
4.1.4 Genomic Health Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
4.1.5 Genomic Health Prostate Cancer Diagnostics Revenue by Product
4.1.6 Genomic Health Prostate Cancer Diagnostics Revenue by Application
4.1.7 Genomic Health Prostate Cancer Diagnostics Revenue by Geographic Area
4.1.8 Genomic Health Prostate Cancer Diagnostics Revenue by Sales Channel
4.1.9 Genomic Health Recent Development
4.2 Abbott
4.2.1 Abbott Corporation Information
4.2.2 Abbott Description, Business Overview
4.2.3 Abbott Prostate Cancer Diagnostics Products Offered
4.2.4 Abbott Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
4.2.5 Abbott Prostate Cancer Diagnostics Revenue by Product
4.2.6 Abbott Prostate Cancer Diagnostics Revenue by Application
4.2.7 Abbott Prostate Cancer Diagnostics Revenue by Geographic Area
4.2.8 Abbott Prostate Cancer Diagnostics Revenue by Sales Channel
4.2.9 Abbott Recent Development
4.3 OPKO
4.3.1 OPKO Corporation Information
4.3.2 OPKO Description, Business Overview
4.3.3 OPKO Prostate Cancer Diagnostics Products Offered
4.3.4 OPKO Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
4.3.5 OPKO Prostate Cancer Diagnostics Revenue by Product
4.3.6 OPKO Prostate Cancer Diagnostics Revenue by Application
4.3.7 OPKO Prostate Cancer Diagnostics Revenue by Geographic Area
4.3.8 OPKO Prostate Cancer Diagnostics Revenue by Sales Channel
4.3.9 OPKO Recent Development
4.4 Siemens Healthcare
4.4.1 Siemens Healthcare Corporation Information
4.4.2 Siemens Healthcare Description, Business Overview
4.4.3 Siemens Healthcare Prostate Cancer Diagnostics Products Offered
4.4.4 Siemens Healthcare Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
4.4.5 Siemens Healthcare Prostate Cancer Diagnostics Revenue by Product
4.4.6 Siemens Healthcare Prostate Cancer Diagnostics Revenue by Application
4.4.7 Siemens Healthcare Prostate Cancer Diagnostics Revenue by Geographic Area
4.4.8 Siemens Healthcare Prostate Cancer Diagnostics Revenue by Sales Channel
4.4.9 Siemens Healthcare Recent Development
4.5 DiaSorin
4.5.1 DiaSorin Corporation Information
4.5.2 DiaSorin Description, Business Overview
4.5.3 DiaSorin Prostate Cancer Diagnostics Products Offered
4.5.4 DiaSorin Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
4.5.5 DiaSorin Prostate Cancer Diagnostics Revenue by Product
4.5.6 DiaSorin Prostate Cancer Diagnostics Revenue by Application
4.5.7 DiaSorin Prostate Cancer Diagnostics Revenue by Geographic Area
4.5.8 DiaSorin Prostate Cancer Diagnostics Revenue by Sales Channel
4.5.9 DiaSorin Recent Development
4.6 BioMeriux
4.6.1 BioMeriux Corporation Information
4.6.2 BioMeriux Description, Business Overview
4.6.3 BioMeriux Prostate Cancer Diagnostics Products Offered
4.6.4 BioMeriux Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
4.6.5 BioMeriux Prostate Cancer Diagnostics Revenue by Product
4.6.6 BioMeriux Prostate Cancer Diagnostics Revenue by Application
4.6.7 BioMeriux Prostate Cancer Diagnostics Revenue by Geographic Area
4.6.8 BioMeriux Recent Development
4.7 Roche
4.7.1 Roche Corporation Information
4.7.2 Roche Description, Business Overview
4.7.3 Roche Prostate Cancer Diagnostics Products Offered
4.7.4 Roche Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
4.7.5 Roche Prostate Cancer Diagnostics Revenue by Product
4.7.6 Roche Prostate Cancer Diagnostics Revenue by Application
4.7.7 Roche Prostate Cancer Diagnostics Revenue by Geographic Area
4.7.8 Roche Recent Development
4.8 MDx Health
4.8.1 MDx Health Corporation Information
4.8.2 MDx Health Description, Business Overview
4.8.3 MDx Health Prostate Cancer Diagnostics Products Offered
4.8.4 MDx Health Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
4.8.5 MDx Health Prostate Cancer Diagnostics Revenue by Product
4.8.6 MDx Health Prostate Cancer Diagnostics Revenue by Application
4.8.7 MDx Health Prostate Cancer Diagnostics Revenue by Geographic Area
4.8.8 MDx Health Recent Development
4.9 Beckman Coulter
4.9.1 Beckman Coulter Corporation Information
4.9.2 Beckman Coulter Description, Business Overview
4.9.3 Beckman Coulter Prostate Cancer Diagnostics Products Offered
4.9.4 Beckman Coulter Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
4.9.5 Beckman Coulter Prostate Cancer Diagnostics Revenue by Product
4.9.6 Beckman Coulter Prostate Cancer Diagnostics Revenue by Application
4.9.7 Beckman Coulter Prostate Cancer Diagnostics Revenue by Geographic Area
4.9.8 Beckman Coulter Recent Development
4.10 Myriad Genetics
4.10.1 Myriad Genetics Corporation Information
4.10.2 Myriad Genetics Description, Business Overview
4.10.3 Myriad Genetics Prostate Cancer Diagnostics Products Offered
4.10.4 Myriad Genetics Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
4.10.5 Myriad Genetics Prostate Cancer Diagnostics Revenue by Product
4.10.6 Myriad Genetics Prostate Cancer Diagnostics Revenue by Application
4.10.7 Myriad Genetics Prostate Cancer Diagnostics Revenue by Geographic Area
4.10.8 Myriad Genetics Recent Development
4.11 Ambry Genetics
4.11.1 Ambry Genetics Corporation Information
4.11.2 Ambry Genetics Description, Business Overview
4.11.3 Ambry Genetics Prostate Cancer Diagnostics Products Offered
4.11.4 Ambry Genetics Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
4.11.5 Ambry Genetics Prostate Cancer Diagnostics Revenue by Product
4.11.6 Ambry Genetics Prostate Cancer Diagnostics Revenue by Application
4.11.7 Ambry Genetics Prostate Cancer Diagnostics Revenue by Geographic Area
4.11.8 Ambry Genetics Recent Development
5 Breakdown Data by Type
5.1 Global Prostate Cancer Diagnostics Sales by Type (2015-2026)
5.1.1 Global Prostate Cancer Diagnostics Sales by Type (2015-2020)
5.1.2 Global Prostate Cancer Diagnostics Sales Forecast by Type (2021-2026)
5.1.3 Global Prostate Cancer Diagnostics Sales Market Share by Type (2015-2026)
5.2 Global Prostate Cancer Diagnostics Revenue Forecast by Type (2015-2026)
5.2.1 Global Prostate Cancer Diagnostics Revenue by Type (2015-2020)
5.2.2 Global Prostate Cancer Diagnostics Revenue Forecast by Type (2021-2026)
5.2.3 Global Prostate Cancer Diagnostics Revenue Market Share by Type (2015-2026)
5.3 Prostate Cancer Diagnostics Average Selling Price (ASP) by Type (2015-2026)
6 Breakdown Data by Application
6.1 Global Prostate Cancer Diagnostics Sales by Application (2015-2026)
6.1.1 Global Prostate Cancer Diagnostics Sales by Application (2015-2020)
6.1.2 Global Prostate Cancer Diagnostics Sales Forecast by Application (2021-2026)
6.1.3 Global Prostate Cancer Diagnostics Sales Market Share by Application (2015-2026)
6.2 Global Prostate Cancer Diagnostics Revenue Forecast by Application (2015-2026)
6.2.1 Global Prostate Cancer Diagnostics Revenue by Application (2015-2020)
6.2.2 Global Prostate Cancer Diagnostics Revenue Forecast by Application (2021-2026)
6.2.3 Global Prostate Cancer Diagnostics Revenue Market Share by Application (2015-2026)
6.3 Prostate Cancer Diagnostics Average Selling Price (ASP) by Application (2015-2026)
7 North America
7.1 North America Prostate Cancer Diagnostics Market Size YoY Growth 2015-2026
7.2 North America Prostate Cancer Diagnostics Market Facts & Figures by Country
7.2.1 North America Prostate Cancer Diagnostics Sales by Country (2015-2026)
7.2.2 North America Prostate Cancer Diagnostics Revenue by Country (2015-2026)
7.3 North America Prostate Cancer Diagnostics Sales by Type
7.4 North America Prostate Cancer Diagnostics Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Diagnostics Market Size YoY Growth 2015-2026
8.2 Asia-Pacific Prostate Cancer Diagnostics Market Facts & Figures by Region
8.2.1 Asia-Pacific Prostate Cancer Diagnostics Sales by Region (2015-2026)
8.2.2 Asia-Pacific Prostate Cancer Diagnostics Revenue by Region (2015-2026)
8.3 Asia-Pacific Prostate Cancer Diagnostics Sales by Type
8.4 Asia-Pacific Prostate Cancer Diagnostics Sales by Application
9 Europe
9.1 Europe Prostate Cancer Diagnostics Market Size YoY Growth 2015-2026
9.2 Europe Prostate Cancer Diagnostics Market Facts & Figures by Country
9.2.1 Europe Prostate Cancer Diagnostics Sales by Country (2015-2026)
9.2.2 Europe Prostate Cancer Diagnostics Revenue by Country (2015-2026)
9.3 Europe Prostate Cancer Diagnostics Sales by Type
9.4 Europe Prostate Cancer Diagnostics Sales by Application
10 Latin America
10.1 Latin America Prostate Cancer Diagnostics Market Size YoY Growth 2015-2026
10.2 Latin America Prostate Cancer Diagnostics Market Facts & Figures by Country
10.2.1 Latin America Prostate Cancer Diagnostics Sales by Country (2015-2026)
10.2.2 Latin America Prostate Cancer Diagnostics Revenue by Country (2015-2026)
10.3 Latin America Prostate Cancer Diagnostics Sales by Type
10.4 Latin America Prostate Cancer Diagnostics Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Prostate Cancer Diagnostics Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Prostate Cancer Diagnostics Market Facts & Figures by Country
11.2.1 Middle East and Africa Prostate Cancer Diagnostics Sales by Country (2015-2026)
11.2.2 Middle East and Africa Prostate Cancer Diagnostics Revenue by Country (2015-2026)
11.3 Middle East and Africa Prostate Cancer Diagnostics Sales by Type
11.4 Middle East and Africa Prostate Cancer Diagnostics Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Prostate Cancer Diagnostics Supply Chain Analysis
12.2 Prostate Cancer Diagnostics Key Raw Materials and Upstream Suppliers
12.3 Prostate Cancer Diagnostics Clients Analysis
12.4 Prostate Cancer Diagnostics Sales Channel and Sales Model Analysis
12.4.1 Prostate Cancer Diagnostics Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Prostate Cancer Diagnostics Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Prostate Cancer Diagnostics Distributors
13 Market Dynamics
13.1 Prostate Cancer Diagnostics Market Drivers
13.2 Prostate Cancer Diagnostics Market Opportunities
13.3 Prostate Cancer Diagnostics Market Challenges
13.4 Prostate Cancer Diagnostics Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Prostate Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Major Manufacturers of Tumor Biomarker Tests
Table 3. Major Manufacturers of Imaging
Table 4. Major Manufacturers of Biopsy
Table 5. Major Manufacturers of Other
Table 6. Global Prostate Cancer Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Prostate Cancer Diagnostics Market Size by Region (US$ Million): 2020 VS 2026
Table 8. Global Prostate Cancer Diagnostics Sales by Region (2015-2020) & (K Units)
Table 9. Global Prostate Cancer Diagnostics Sales Forecast by Region (2021-2026) & (K Units)
Table 10. Global Prostate Cancer Diagnostics Revenue by Region (2015-2020) & (US$ Million)
Table 11. Global Prostate Cancer Diagnostics Revenue Forecast by Region (2021-2026) & (US$ Million)
Table 12. Global Prostate Cancer Diagnostics Sales by Manufacturer (2015-2020) & (K Units)
Table 13. Global Prostate Cancer Diagnostics Sales Share by Manufacturer (2015-2020)
Table 14. Prostate Cancer Diagnostics Revenue by Manufacturer (2015-2020) & (US$ Million)
Table 15. Prostate Cancer Diagnostics Revenue Share by Manufacturer (2015-2020)
Table 16. Key Manufacturers Prostate Cancer Diagnostics Price (2015-2020) & (USD/Unit)
Table 17. Ranking of Global Top Prostate Cancer Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 18. Global Prostate Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI) & (2015-2020)
Table 19. Global Prostate Cancer Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics as of 2019)
Table 20. Prostate Cancer Diagnostics Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Prostate Cancer Diagnostics Product Type
Table 22. Date of International Manufacturers Enter into Prostate Cancer Diagnostics Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Genomic Health Corporation Information
Table 25. Genomic Health Description and Business Overview
Table 26. Genomic Health Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 27. Genomic Health Prostate Cancer Diagnostics Product
Table 28. Genomic Health Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Product
Table 29. Genomic Health Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Application
Table 30. Genomic Health Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Geographic Area
Table 31. Genomic Health Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Sales Channel
Table 32. Genomic Health Recent Development
Table 33. Abbott Corporation Information
Table 34. Abbott Description and Business Overview
Table 35. Abbott Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 36. Abbott Prostate Cancer Diagnostics Product
Table 37. Abbott Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Product
Table 38. Abbott Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Application
Table 39. Abbott Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Geographic Area
Table 40. Abbott Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Sales Channel
Table 41. Abbott Recent Development
Table 42. OPKO Corporation Information
Table 43. OPKO Description and Business Overview
Table 44. OPKO Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 45. OPKO Prostate Cancer Diagnostics Product
Table 46. OPKO Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Product
Table 47. OPKO Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Application
Table 48. OPKO Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Geographic Area
Table 49. OPKO Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Sales Channel
Table 50. OPKO Recent Development
Table 51. Siemens Healthcare Corporation Information
Table 52. Siemens Healthcare Description and Business Overview
Table 53. Siemens Healthcare Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 54. Siemens Healthcare Prostate Cancer Diagnostics Product
Table 55. Siemens Healthcare Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Product
Table 56. Siemens Healthcare Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Application
Table 57. Siemens Healthcare Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Geographic Area
Table 58. Siemens Healthcare Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Sales Channel
Table 59. Siemens Healthcare Recent Development
Table 60. DiaSorin Corporation Information
Table 61. DiaSorin Description and Business Overview
Table 62. DiaSorin Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 63. DiaSorin Prostate Cancer Diagnostics Product
Table 64. DiaSorin Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Product
Table 65. DiaSorin Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Application
Table 66. DiaSorin Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Geographic Area
Table 67. DiaSorin Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Sales Channel
Table 68. DiaSorin Recent Development
Table 69. BioMeriux Corporation Information
Table 70. BioMeriux Description and Business Overview
Table 71. BioMeriux Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. BioMeriux Prostate Cancer Diagnostics Product
Table 73. BioMeriux Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Product
Table 74. BioMeriux Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Application
Table 75. BioMeriux Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Geographic Area
Table 76. BioMeriux Recent Development
Table 77. Roche Corporation Information
Table 78. Roche Description and Business Overview
Table 79. Roche Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Roche Prostate Cancer Diagnostics Product
Table 81. Roche Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Product
Table 82. Roche Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Application
Table 83. Roche Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Geographic Area
Table 84. Roche Recent Development
Table 85. MDx Health Corporation Information
Table 86. MDx Health Description and Business Overview
Table 87. MDx Health Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. MDx Health Prostate Cancer Diagnostics Product
Table 89. MDx Health Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Product
Table 90. MDx Health Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Application
Table 91. MDx Health Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Geographic Area
Table 92. MDx Health Recent Development
Table 93. Beckman Coulter Corporation Information
Table 94. Beckman Coulter Description and Business Overview
Table 95. Beckman Coulter Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Beckman Coulter Prostate Cancer Diagnostics Product
Table 97. Beckman Coulter Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Product
Table 98. Beckman Coulter Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Application
Table 99. Beckman Coulter Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Geographic Area
Table 100. Beckman Coulter Recent Development
Table 101. Myriad Genetics Corporation Information
Table 102. Myriad Genetics Description and Business Overview
Table 103. Myriad Genetics Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Myriad Genetics Prostate Cancer Diagnostics Product
Table 105. Myriad Genetics Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Product
Table 106. Myriad Genetics Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Application
Table 107. Myriad Genetics Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Geographic Area
Table 108. Myriad Genetics Recent Development
Table 109. Ambry Genetics Corporation Information
Table 110. Ambry Genetics Description and Business Overview
Table 111. Ambry Genetics Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Ambry Genetics Prostate Cancer Diagnostics Product
Table 113. Ambry Genetics Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Product
Table 114. Ambry Genetics Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Application
Table 115. Ambry Genetics Prostate Cancer Diagnostics Revenue (US$ Million) and Market Share by Geographic Area
Table 116. Ambry Genetics Recent Development
Table 117. Global Prostate Cancer Diagnostics Sales by Type (2015-2020) & (K Units)
Table 118. Global Prostate Cancer Diagnostics Sales Forecast by Type (2021-2026) & (K Units)
Table 119. Global Prostate Cancer Diagnostics Revenue by Type (2015-2020) & (US$ Million)
Table 120. Global Prostate Cancer Diagnostics Revenue Forecast by Type (2021-2026) & (US$ Million)
Table 121. Global Prostate Cancer Diagnostics Sales by Application (2015-2020) & (K Units)
Table 122. Global Prostate Cancer Diagnostics Sales Forecast by Application (2021-2026) & (K Units)
Table 123. Global Prostate Cancer Diagnostics Revenue by Application (2015-2020) & (US$ Million)
Table 124. Global Prostate Cancer Diagnostics Revenue Forecast by Application (2021-2026) & (US$ Million)
Table 125. North America Prostate Cancer Diagnostics Sales by Country (2015-2020) & (K Units)
Table 126. North America Prostate Cancer Diagnostics Sales by Country (2021-2026) & (K Units)
Table 127. North America Prostate Cancer Diagnostics Revenue by Country (2015-2020) & (US$ Million)
Table 128. North America Prostate Cancer Diagnostics Revenue by Country (2021-2026) & (US$ Million)
Table 129. North America Prostate Cancer Diagnostics Sales by Type (2015-2020) & (K Units)
Table 130. North America Prostate Cancer Diagnostics Sales by Application (2015-2020) & (K Units)
Table 131. Asia-Pacific Prostate Cancer Diagnostics Sales by Region (2015-2020) & (K Units)
Table 132. Asia-Pacific Prostate Cancer Diagnostics Sales by Region (2021-2026) & (K Units)
Table 133. Asia-Pacific Prostate Cancer Diagnostics Revenue by Region (2015-2026) & (US$ Million)
Table 134. Asia-Pacific Prostate Cancer Diagnostics Revenue by Region (2021-2026) & (US$ Million)
Table 135. Asia-Pacific Prostate Cancer Diagnostics Sales by Type (2015-2020) & (K Units)
Table 136. Asia-Pacific Prostate Cancer Diagnostics Sales by Application (2015-2020) & (K Units)
Table 137. Europe Prostate Cancer Diagnostics Sales by Country (2015-2020) & (K Units)
Table 138. Europe Prostate Cancer Diagnostics Sales by Country (2021-2026) & (K Units)
Table 139. Europe Prostate Cancer Diagnostics Revenue by Country (2015-2020) & (US$ Million)
Table 140. Europe Prostate Cancer Diagnostics Revenue by Country (2021-2026) & (US$ Million)
Table 141. Europe Prostate Cancer Diagnostics Sales by Type (2015-2020) & (K Units)
Table 142. Europe Prostate Cancer Diagnostics Sales by Application (2015-2020) & (K Units)
Table 143. Latin America Prostate Cancer Diagnostics Sales by Country (2015-2020) & (K Units)
Table 144. Latin America Prostate Cancer Diagnostics Sales by Country (2021-2026) & (K Units)
Table 145. Latin America Prostate Cancer Diagnostics Revenue by Country (2015-2020) & (US$ Million)
Table 146. Latin America Prostate Cancer Diagnostics Revenue by Country (2021-2026) & (US$ Million)
Table 147. Latin America Prostate Cancer Diagnostics Sales by Type (2015-2020) & (K Units)
Table 148. Latin America Prostate Cancer Diagnostics Sales by Application (2015-2020) & (K Units)
Table 149. Middle East and Africa Prostate Cancer Diagnostics Sales by Country (2015-2020) & (K Units)
Table 150. Middle East and Africa Prostate Cancer Diagnostics Sales by Country (2021-2026) & (K Units)
Table 151. Middle East and Africa Prostate Cancer Diagnostics Revenue by Country (2015-2020) & (US$ Million)
Table 152. Middle East and Africa Prostate Cancer Diagnostics Revenue by Country (2021-2026) & (US$ Million)
Table 153. Middle East and Africa Prostate Cancer Diagnostics Sales by Type (2015-2020) & (K Units)
Table 154. Middle East and Africa Prostate Cancer Diagnostics Sales by Application (2015-2020) & (K Units)
Table 155. Prostate Cancer Diagnostics Key Raw Materials, Industry Status and Trend
Table 156. Prostate Cancer Diagnostics Key Raw Materials and Upstream Suppliers
Table 157. Prostate Cancer Diagnostics Clients Status and Trend
Table 158. Prostate Cancer Diagnostics Typical Clients
Table 159. Prostate Cancer Diagnostics Distributors
Table 160. Key Drivers: Impact Analysis (2021-2026)
Table 161. Prostate Cancer Diagnostics Market Drivers
Table 162. Prostate Cancer Diagnostics Market Opportunities
Table 163. Prostate Cancer Diagnostics Market Challenges
Table 164. Prostate Cancer Diagnostics Market Restraints
Table 165. Prostate Cancer Diagnostics Porter's Five Forces Analysis
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Prostate Cancer Diagnostics Product Picture
Figure 2. Global Prostate Cancer Diagnostics Sales Market Share by Type in 2020 & 2026
Figure 3. Tumor Biomarker Tests Product Picture
Figure 4. Imaging Product Picture
Figure 5. Biopsy Product Picture
Figure 6. Other Product Picture
Figure 7. Global Prostate Cancer Diagnostics Sales Market Share by Application in 2020 & 2026
Figure 8. age < 55 Examples
Figure 9. age 55-75 Examples
Figure 10. age > 75 Examples
Figure 11. Prostate Cancer Diagnostics Report Years Considered
Figure 12. Global Prostate Cancer Diagnostics Market Size, (US$ Million), 2015 VS 2020 VS 2026
Figure 13. Global Prostate Cancer Diagnostics Market Size 2015-2026 (US$ Million)
Figure 14. Global Prostate Cancer Diagnostics Sales 2015-2026 (K Units)
Figure 15. Global Prostate Cancer Diagnostics Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Prostate Cancer Diagnostics Sales Market Share Forecast by Region (2015-2026)
Figure 17. Global Prostate Cancer Diagnostics Revenue Market Share by Region (2015-2026)
Figure 18. Global Prostate Cancer Diagnostics Sales Share by Manufacturer in 2019
Figure 19. Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Prostate Cancer Diagnostics Sales Market Share Forecast by Type (2015-2026)
Figure 21. Global Prostate Cancer Diagnostics Revenue Market Share Forecast by Type (2015-2026)
Figure 22. Prostate Cancer Diagnostics Average Selling Price (ASP) by Type (2015-2020) & (USD/Unit)
Figure 23. Global Prostate Cancer Diagnostics Sales Market Share Forecast by Application (2015-2026)
Figure 24. Global Prostate Cancer Diagnostics Revenue Market Share Forecast by Application (2015-2026)
Figure 25. Prostate Cancer Diagnostics Average Selling Price (ASP) by Application (2015-2020) & (USD/Unit)
Figure 26. North America Prostate Cancer Diagnostics Revenue 2015-2026 (US$ Million)
Figure 27. North America Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020)
Figure 28. North America Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
Figure 29. Asia-Pacific Prostate Cancer Diagnostics Revenue 2015-2026 (US$ Million)
Figure 30. Asia-Pacific Prostate Cancer Diagnostics Sales Market Share by Region (2015-2026)
Figure 31. Asia-Pacific Prostate Cancer Diagnostics Revenue Market Share by Region (2015-2026)
Figure 32. Asia-Pacific Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020)
Figure 33. Asia-Pacific Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
Figure 34. Europe Prostate Cancer Diagnostics Revenue Growth Rate 2015-2026 (US$ Million)
Figure 35. Europe Prostate Cancer Diagnostics Sales Market Share by Country (2015-2026)
Figure 36. Europe Prostate Cancer Diagnostics Revenue Market Share by Country (2015-2026)
Figure 37. Europe Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020)
Figure 38. Europe Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
Figure 39. Latin America Prostate Cancer Diagnostics Revenue Growth Rate 2015-2026 (US$ Million)
Figure 40. Latin America Prostate Cancer Diagnostics Sales Market Share by Country (2015-2026)
Figure 41. Latin America Prostate Cancer Diagnostics Revenue Market Share by Country (2015-2020)
Figure 42. Latin America Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020)
Figure 43. Latin America Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
Figure 44. Middle East and Africa Prostate Cancer Diagnostics Revenue Growth Rate 2015-2026 (US$ Million)
Figure 45. Middle East and Africa Prostate Cancer Diagnostics Sales Market Share by Country (2015-2026)
Figure 46. Middle East and Africa Prostate Cancer Diagnostics Revenue Market Share by Country (2015-2026)
Figure 47. Middle East and Africa Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020)
Figure 48. Middle East and Africa Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
Figure 49. Prostate Cancer Diagnostics Supply Chain (Upstream and Downstream Market)
Figure 50. Global Production Market Share of Prostate Cancer Diagnostics Raw Materials by Region in 2019
Figure 51. Prostate Cancer Diagnostics Distribution Channels
Figure 52. Global Prostate Cancer Diagnostics Percentage 2015-2026: Indirect Sales VS Direct Sales
Figure 53. Global Prostate Cancer Diagnostics Percentage 2015-2026: Online Sales VS Offline Sales
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Prostate Cancer Diagnostics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Prostate Cancer Diagnostics market size was valued at US$ 13140 million in 2023. With growing demand in downstream market, the Prostate Cancer Diagnostics is forecast to a readjusted size of US$ 22650 million by 2030 with a CAGR of 8.1% during review period. The research report highlights the growth potential of the global Prostate Cancer Diagnostics market. Prostate Cancer Diagnostics are expected to show stable growth in th......

Global Checkpoint Inhibitors for Treating Cancer Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 83

According to our LPI (LP Information) latest study, the global Checkpoint Inhibitors for Treating Cancer market size was valued at US$ 12220 million in 2023. With growing demand in downstream market, the Checkpoint Inhibitors for Treating Cancer is forecast to a readjusted size of US$ 63530 million by 2030 with a CAGR of 26.6% during review period. The research report highlights the growth potential of the global Checkpoint Inhibitors for Treating Cancer market. Checkpoint Inhibitors for......

Global PSA Test Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 111

According to our LPI (LP Information) latest study, the global PSA Test market size was valued at US$ 499.9 million in 2023. With growing demand in downstream market, the PSA Test is forecast to a readjusted size of US$ 861.8 million by 2030 with a CAGR of 8.1% during review period. The research report highlights the growth potential of the global PSA Test market. PSA Test are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global HPV Testing Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 87

According to our LPI (LP Information) latest study, the global HPV Testing market size was valued at US$ 784.6 million in 2023. With growing demand in downstream market, the HPV Testing is forecast to a readjusted size of US$ 1398.7 million by 2030 with a CAGR of 8.6% during review period. The research report highlights the growth potential of the global HPV Testing market. HPV Testing are expected to show stable growth in the future market. However, product differentiation, reducing cos......

Global Prostate Cancer Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 102

According to our (Global Info Research) latest study, the global Prostate Cancer Diagnostics market size was valued at USD 13820 million in 2023 and is forecast to a readjusted size of USD 22870 million by 2030 with a CAGR of 7.5% during review period. The prostate is a walnut-sized gland located behind the base of a man's penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be ......

Global Pap Tests and HPV Tests Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 130

The Pap test (or Pap smear) looks for precancers, cell changes on the cervix that might become cervical cancer if they are not treated appropriately. The HPV test looks for the virus (human papillomavirus) that can cause these cell changes. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can......

Global Pap Tests and HPV Tests Professional Survey Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 3280 Onwards        Pages: 106

The Pap test (or Pap smear) looks for precancers, cell changes on the cervix that might become cervical cancer if they are not treated appropriately. The HPV test looks for the virus (human papillomavirus) that can cause these cell changes. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can......

Global Checkpoint Inhibitors For Treating Cancer Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 102

Market Overview of Global Checkpoint Inhibitors For Treating Cancer market: According to our latest research, the global Checkpoint Inhibitors For Treating Cancer market looks promising in the next 5 years. As of 2022, the global Checkpoint Inhibitors For Treating Cancer market was estimated at USD 18595.4 million, and it's anticipated to reach USD 42557.61 million in 2028, with a CAGR of 14.8% during the forecast years. Checkpoint inhibitor is a type of drug used in immunoth......

Global Solid Tumor Testing Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 100

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs